Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.35 HKD | -4.11% | -10.36% | +11.72% |
May. 14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
May. 14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
Sales 2024 * | 677M 93.71M 731M | Sales 2025 * | 1.5B 208M 1.62B | Capitalization | 7.22B 1B 7.8B |
---|---|---|---|---|---|
Net income 2024 * | -646M -89.48M -698M | Net income 2025 * | -160M -22.16M -173M | EV / Sales 2024 * | 9.34 x |
Net cash position 2024 * | 901M 125M 973M | Net cash position 2025 * | 336M 46.54M 363M | EV / Sales 2025 * | 4.59 x |
P/E ratio 2024 * |
-11
x | P/E ratio 2025 * |
-44.8
x | Employees | 432 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.82% |
Latest transcript on Everest Medicines Limited
1 day | -3.90% | ||
1 week | -10.17% | ||
Current month | -4.29% | ||
1 month | +1.08% | ||
3 months | +37.49% | ||
6 months | -15.06% | ||
Current year | +11.96% |
Managers | Title | Age | Since |
---|---|---|---|
Yong Qing Luo
CEO | Chief Executive Officer | 54 | 22-09-18 |
Ian Ying Woo
PSD | President | 51 | 18-11-30 |
Michael Berry
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Fan Li
BRD | Director/Board Member | 55 | 20-08-31 |
Honggang Feng
BRD | Director/Board Member | 59 | Feb. 08 |
Wei Fu
CHM | Chairman | 42 | 17-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.75% | 4 M€ | -27.92% | ||
0.01% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +5.51% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 23.35 | -4.11% | 5 464 500 |
24-05-16 | 24.35 | -4.88% | 6,038,300 |
24-05-14 | 25.6 | +1.59% | 6,381,221 |
24-05-13 | 25.2 | -3.26% | 4,289,107 |
24-05-10 | 26.05 | +3.78% | 4,477,822 |
Delayed Quote Hong Kong S.E., May 17, 2024 at 03:28 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.96% | 1B | |
-2.32% | 92.59B | |
+3.16% | 41.43B | |
-11.10% | 33.49B | |
+53.42% | 25.06B | |
-9.41% | 12.77B | |
-12.25% | 11.58B | |
-44.00% | 11.35B | |
+5.92% | 8.97B | |
-5.96% | 8.3B |
- Stock Market
- Equities
- 1952 Stock